Autobio Diagnostics Co (SHSE:603658) Debt-to-Equity : 0.09 (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Autobio Diagnostics Co Debt-to-Equity?

Autobio Diagnostics Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥491 Mil. Autobio Diagnostics Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥264 Mil. Autobio Diagnostics Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥8,780 Mil. Autobio Diagnostics Co's debt to equity for the quarter that ended in Mar. 2024 was 0.09.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Autobio Diagnostics Co's Debt-to-Equity or its related term are showing as below:

SHSE:603658' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01 Med: 0.05 Max: 0.36
Current: 0.09

During the past 13 years, the highest Debt-to-Equity Ratio of Autobio Diagnostics Co was 0.36. The lowest was 0.01. And the median was 0.05.

SHSE:603658's Debt-to-Equity is ranked better than
69.87% of 707 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs SHSE:603658: 0.09

Autobio Diagnostics Co Debt-to-Equity Historical Data

The historical data trend for Autobio Diagnostics Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Autobio Diagnostics Co Debt-to-Equity Chart

Autobio Diagnostics Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.31

0.04

0.03

0.02

0.09

Autobio Diagnostics Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial															0.05	0.07	0.08	0.09	0.09

Competitive Comparison of Autobio Diagnostics Co's Debt-to-Equity

For the Medical Devices subindustry, Autobio Diagnostics Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Autobio Diagnostics Co's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Autobio Diagnostics Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Autobio Diagnostics Co's Debt-to-Equity falls into.

Autobio Diagnostics Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Autobio Diagnostics Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(698.521	+	24.636)	/	8535.462
	=	0.08

Autobio Diagnostics Co's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(491.335	+	263.667)	/	8779.842
	=	0.09

Autobio Diagnostics Co (SHSE:603658) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Autobio Diagnostics Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Autobio Diagnostics Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Autobio Diagnostics Co (SHSE:603658) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Autobio Diagnostics Co Ltd (SHSE:603658) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.199, 15th Avenue, National Economic and Technological Development Area, Zhengzhou, CHN, 450016

Website

http://www.autobio.com.cn

Autobio Diagnostics Co Ltd is a clinical diagnostics company in China. It specializes in research and development, production, marketing and service of clinical diagnostic products, including immunoassay, microbiology and biochemical products. It focuses on the common development of both reagents and instruments. Reagents products include immunoassay, biochemistry, microbiology, and IVD subdivision areas, and instruments include both full automation and semi-automation instruments and systems. Geographically it holds a strong distribution network with thousands of distributors in the Chinese market.

Autobio Diagnostics Co (SHSE:603658) Headlines

No Headlines